[{"id":"2dddb07c-6604-4201-9537-35dbc579cb0b","acronym":"","url":"https://clinicaltrials.gov/study/NCT03574168","created_at":"2021-01-18T17:35:12.083Z","updated_at":"2024-07-02T16:37:09.365Z","phase":"Phase 1","brief_title":"CD19-CAR-T Cells in Patients With R/R B-ALL","source_id_and_acronym":"NCT03574168","lead_sponsor":"Bioceltech Therapeutics, Ltd.","biomarkers":" CD19","pipe":" | ","alterations":" CD19 expression","tags":["CD19"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CD19 expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e anti-CD19 CAR-T cell therapy"],"overall_status":"Unknown status","enrollment":" Enrollment 40","initiation":"Initiation: 07/20/2018","start_date":" 07/20/2018","primary_txt":" Primary completion: 12/31/2019","primary_completion_date":" 12/31/2019","study_txt":" Completion: 12/31/2019","study_completion_date":" 12/31/2019","last_update_posted":"2018-06-29"}]